Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Практический подход к диагностике рецидивирующих головных болей и возможности применения нестероидных противовоспалительных препаратов
Практический подход к диагностике рецидивирующих головных болей и возможности применения нестероидных противовоспалительных препаратов
Табеева Г.Р., Кирьянова Е.А. Практический подход к диагностике рецидивирующих головных болей и возможности применения нестероидных противовоспалительных препаратов. Consilium Medicum. 2021; 23 (2): 148–153. DOI: 10.26442/20751753.2021.2.200728
________________________________________________
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Аннотация
Основное бремя головной боли (ГБ) в мире приходится на первичные цефалгии (ГБ напряжения, мигрень). Тем не менее часто имеется необходимость исключить вторичную причину ГБ. В обзоре приведены основные варианты дифференциальной диагностики цефалгий, учитывающие возраст пациента, характеристики ГБ и анамнестические сведения. Обсуждается роль нестероидных противовоспалительных препаратов в лечении ГБ, их безопасность при длительном приеме и профилактика лекарственно-индуцированной ГБ.
Ключевые слова: первичные и вторичные головные боли, головная боль напряжения, мигрень, лекарственно-индуцированная головная боль, громоподобная головная боль, COVID-19, нестероидные противовоспалительные препараты, ибупрофен
Keywords: primary and secondary headaches, tension headache, migraine, medication-overuse headache, thunderclap headache, COVID-19, nonsteroidal anti-inflammatory drugs, ibuprofen
Ключевые слова: первичные и вторичные головные боли, головная боль напряжения, мигрень, лекарственно-индуцированная головная боль, громоподобная головная боль, COVID-19, нестероидные противовоспалительные препараты, ибупрофен
________________________________________________
Keywords: primary and secondary headaches, tension headache, migraine, medication-overuse headache, thunderclap headache, COVID-19, nonsteroidal anti-inflammatory drugs, ibuprofen
Полный текст
Список литературы
1. Stovner L, Hagen K, Jensen R. The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia. 2007; 27 (3): 193–210. DOI: 10.1111/j.1468-2982.2007.01288.x
2. Vos T, Flaxman AD, Naghavi M. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380 (9859): 2163–96. DOI: 10.1016/S0140-6736(12)61729-2
3. GBD 2015 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016; 388 (10053): 1603–58. DOI: 10.1016/S0140-6736(16)31460-X
4. Saylor D, Steiner TJ. The global burden of headache. Semin Neurol. 2018; 38 (2): 182–90. DOI: 10.1055/s-00000071
5. Ayzenberg I, Katsarava Z, Sborowski A. Headache-attributed burden and its impact on productivity and quality of life in Russia: structured healthcare for headache is urgently needed. Eur J Neurol. 2014; 21 (05): 758–65. DOI: 10.1111/ene.12380
6. Mukendi D, Lilo Kalo JR, Mpanya A. Clinical spectrum, etiology, and outcome of neurological disorders in the rural hospital of Mosango, the Democratic Republic of Congo. Am J Trop Med Hyg. 2017; 97 (05): 1454–60. DOI: 10.4269/ajtmh.17-0375
7. Gatti F, Manneschi L. Headache relevance in outpatient activity during Covid-19 pandemic. Neurol Sci. 2020; 41 (2): 481–2. DOI: 10.1007/s10072-020-04666-1
8. Ong JJY, Bharatendu C, Goh Y, et al. Headaches Associated with Personal Protective Equipment – a cross-sectional study amongst frontline healthcare workers during COVID-19 (HAPPE Study). Headache. 2020; 60: 864–77. DOI: 10.1111/head.13811
9. Caronna E, Ballvé A, Llauradó A, et al. Headache: A striking prodromal and persistent symptom, predictive of COVID-19 clinical evolution. Cephalalgia. 2020; 40 (13): 1410–21. DOI: 10.1177/0333102420965157
10. Pohl H, Do TP, García-Azorín D, et al. Green Flags and headache: A concept study using the Delphi method. Headache. 2021; 61 (2): 300–9. DOI: 10.1111/head.14054
11. Наприенко М.В., Филатова Е.Г., Смекалкина Л.В., Макаров С.А. Головная боль напряжения. Повторение пройденного. Consilium Medicum. 2019; 21 (2): 79–85 [Naprienko MV, Filatova EG, Smekalkina LV, Makarov SA. Tension headache. Let us get a second look. Consilium Medicum. 2019; 21 (2): 79–85 (in Russian)]. DOI: 10.26442/20751753.2019.2.190281
12. Осипова В.В., Филатова Е.Г., Артеменко А.Р., и др. Диагностика и лечение мигрени: рекомендации российских экспертов. Журнал неврологии и психиатрии им. С.С. Корсакова. 2017; 117 (1–2): 28–42 [Filatova EG, Osipova VV, Tabeeva GR, et al. Diagnosis and treatment of migraine: Recommendations of the Russian experts. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 2017; 117 (1–2): 28–42 (in Russian)]. DOI: 10.17116/jnevro20171171228-42
13. Longoni M, Agostoni EC. Headache in neurological emergency. Neurol Sci. 2020; 41 (2): 409–16. DOI: 10.1007/s10072-020-04761-3
14. Headache Classification Committee of the International Headache Society. HIS The International Classification of Headache Disorders, 3rd ed. Cephalalgia. 2018; 38 (1): 1–211. DOI: 10.1177/0333102417738202
15. Rosenberg JH, Silberstein SD. The headache of SAH responds to sumatriptan. Headache. 2005; 45: 597. DOI: 10.1111/j.1526-4610.2005.05114.x
16. Leira EC, Cruz-Flores S, Leacock RO. Sumatriptan can alleviate headaches due to carotid artery dissection. Headache. 2001; 41: 590. DOI: 10.1046/j.1526-4610.2001.041006590.x
17. Prokhorov S, Khanna S, Alapati D. Subcutaneous sumatriptan relieved migraine-like headache in two adolescents with aseptic meningitis. Headache. 2008; 48: 1235. DOI: 10.1111/j.1526-4610.2008.01151.x
18. Lipton RB, Mazer C, Newman LC. Sumatriptan relieves migraine-like headaches associated with carbon monoxide exposure. Headache. 1997; 37: 392. DOI: 10.1046/j.1526-4610.1997.3706392.x
19. Luciani M, Negro A, Spunatrelli V, et al. Evaluating and managing severe headache in the emergency department. Expert Rev Neurother. 2021; 21 (3): 277–85. DOI: 10.1080/14737175.2021.1863148
20. Förderreuther S. Kopfschmerzen als Notfall sind leicht übersehen. Schmerz. 2020; 34: 517–24. DOI: 10.1007/s00482-020-00513-6
21. Vidale S. Headache in cervicocerebral artery dissection. Neurol Sci. 2020; 41: 395–9.
DOI: 10.1007/s10072-020-04651-8
22. Diamanti S, Longoni M, Agostoni EC. Leading symptoms in cerebrovascular diseases: what about headache? Neurol Sci. 2019; 40 (1): 147–52. DOI: 10.1007/s10072-019-03793-8
23. Tarulli A. Headache and Facial Pain. Neurology. 2020: 265–87. DOI: 10.1007/978-3-030-55598-6_19
24. Sekhon S, Sharma R, Cascella M. Thunderclap Headache. In: StatPearls. Treasure Island: StatPearls Publishing, 2020.
25. Miller TR, Shivashankar R, Mossa-Basha M, Gandhi D. Reversible Cerebral Vasoconstriction Syndrome, Part 1: Epidemiology, Pathogenesis, and Clinical Course. Am J Neuroradiol. 2015; 36 (8): 1392–9. DOI: 10.3174/ajnr.A4214
26. Ju YE, Schwedt TJ. Abrupt-onset severe headaches. Semin Neurol. 2010; 30 (2): 192–200.
DOI: 10.1055/s-0030-1249229
27. Devenney E, Neale H, Forbes RB. A systematic review of causes of sudden and severe headache (Thunderclap Headache): should lists be evidence based? J Headache Pain. 2014; 15 (1): 49. DOI: 10.1186/1129-2377-15-49
28. Joshi SG, Cho TA. Pathophysiological mechanisms of headache in patients with HIV. Headache. 2014; 54 (5): 946–50. DOI: 10.1111/head.12356
29. Brouwer MC, Coutinho JM, van de Beek D. Clinical characteristics and outcome of brain abscess: systematic review and meta-analysis. Neurology. 2014; 82 (9): 806–13. DOI: 10.1212/WNL.0000000000000172
30. Schankin CJ, Ferrari U, Reinisch VM. Characteristics of brain tumour-associated headache. Cephalalgia. 2007; 27 (8): 904–11. DOI: 10.1111/j.1468-2982.2007.01368.x
31. Palmieri A, Valentinis L, Zanchin G. Update on headache and brain tumors. Cephalalgia. 2020: 0333102420974351. DOI: 10.1177/0333102420974351
32. Чечет Е.А., Табеева Г.Р. Цервикогенная головная боль. Медицинский совет. 2015; 4: 76–81. Режим доступа: https://cyberleninka.ru/article/n/tservikogennaya-golovnaya-bol-2. Ссылка активна на 07.04.2021 [Chechet EA, Tabeeva GR. Tservikogennaia golovnaia bol'. Meditsinskii sovet. 2015; 4: 76–81. Available at: https://cyberleninka.ru/article/n/tservikogennaya-golovnaya-bol-2. Accessed: 07.04.2021 (in Russian)].
33. Aliprandi A, Borelli P, Polonia V, Salmaggi A. Headache in cerebral venous thrombosis. Neurol Sci. 2020; 41 (2): 401–6. DOI: 10.1007/s10072-020-04784-w
34. Aladakatti R, Sannakki LB, Cai PY, Derequito R. Thunderclap headache: It is always sub-arachnoid hemorrhage. Is it? A case report and Review. Surg Neurol Int. 2014; 5: 22. DOI: 10.4103/2152-7806.127756
35. Negro A, Spuntarelli V, Sciattella P. Rapid referral for headache management from emergency department to headache centre: four years data. J Headache Pain. 2020; 21 (25): 1–11. DOI: 10.1186/s10194-020-01094-6
36. Valade D, Lucas C, Calvel L. Migraine diagnosis and management in general emergency departments in France. Cephalalgia. 2011; 31: 471–80. DOI: 10.1177/0333102410378178
37. Gupta MX, Silberstein SD, Young WB. Less is not more: Underutilization of headache medications in a university hospital emergency department. Headache. 2007; 47: 1125–33. DOI: 10.1111/j.1526-4610.2007.00846.x
38. Varrassi G, Pergolizzi JV, Dowling P, Paladini A. Ibuprofen safety at the golden anniversary: are all NSAIDs the same? A narrative review. Adv Ther. 2020; 37 (1): 61–82. DOI: 10.1007/s12325-019-01144-9
39. Moore RA, Derry S, Straube S, et al. Faster, higher, stronger? Evidence for formulation and efficacy for ibuprofen in acute pain. Pain. 2014; 155 (1): 14–21. DOI: 10.1016/j.pain.2013.08.013
40. Moore RA, Derry S, McQuay HJ, Wiffen PJ. Single dose oral analgesics for acute postoperative pain in adults. Cochrane Database Syst Rev. 2011: CD008659. DOI: 10.1002/14651858.CD008659.pub3
41. Van Den Brink MA, de Vries T, Danser AHJ. Headache medication and the COVID-19 pandemic.
J Headache Pain. 2020; 21 (1): 38. DOI: 10.1186/s10194-020-01106-5
42. Peck J, Urits I, Zeien J, et al. A Comprehensive Review of Over-the-counter Treatment for Chronic Migraine Headaches. Curr Pain Headache Rep. 2020; 24 (5): 19. DOI: 10.1007/s11916-020-00852-0
43. Rabbie R, Derry S, Moore RA, McQuay HJ. Ibuprofen with or without an antiemetic for acute migraine headaches in adults. Cochrane Database Syst Rev. 2010; 4. DOI: 10.1002/14651858.CD008039.pub2
2. Vos T, Flaxman AD, Naghavi M. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380 (9859): 2163–96. DOI: 10.1016/S0140-6736(12)61729-2
3. GBD 2015 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016; 388 (10053): 1603–58. DOI: 10.1016/S0140-6736(16)31460-X
4. Saylor D, Steiner TJ. The global burden of headache. Semin Neurol. 2018; 38 (2): 182–90. DOI: 10.1055/s-00000071
5. Ayzenberg I, Katsarava Z, Sborowski A. Headache-attributed burden and its impact on productivity and quality of life in Russia: structured healthcare for headache is urgently needed. Eur J Neurol. 2014; 21 (05): 758–65. DOI: 10.1111/ene.12380
6. Mukendi D, Lilo Kalo JR, Mpanya A. Clinical spectrum, etiology, and outcome of neurological disorders in the rural hospital of Mosango, the Democratic Republic of Congo. Am J Trop Med Hyg. 2017; 97 (05): 1454–60. DOI: 10.4269/ajtmh.17-0375
7. Gatti F, Manneschi L. Headache relevance in outpatient activity during Covid-19 pandemic. Neurol Sci. 2020; 41 (2): 481–2. DOI: 10.1007/s10072-020-04666-1
8. Ong JJY, Bharatendu C, Goh Y, et al. Headaches Associated with Personal Protective Equipment – a cross-sectional study amongst frontline healthcare workers during COVID-19 (HAPPE Study). Headache. 2020; 60: 864–77. DOI: 10.1111/head.13811
9. Caronna E, Ballvé A, Llauradó A, et al. Headache: A striking prodromal and persistent symptom, predictive of COVID-19 clinical evolution. Cephalalgia. 2020; 40 (13): 1410–21. DOI: 10.1177/0333102420965157
10. Pohl H, Do TP, García-Azorín D, et al. Green Flags and headache: A concept study using the Delphi method. Headache. 2021; 61 (2): 300–9. DOI: 10.1111/head.14054
11. Naprienko MV, Filatova EG, Smekalkina LV, Makarov SA. Tension headache. Let us get a second look. Consilium Medicum. 2019; 21 (2): 79–85 (in Russian). DOI: 10.26442/20751753.2019.2.190281
12. Filatova EG, Osipova VV, Tabeeva GR, et al. Diagnosis and treatment of migraine: Recommendations of the Russian experts. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 2017; 117 (1–2): 28–42 (in Russian). DOI: 10.17116/jnevro20171171228-42
13. Longoni M, Agostoni EC. Headache in neurological emergency. Neurol Sci. 2020; 41 (2): 409–16. DOI: 10.1007/s10072-020-04761-3
14. Headache Classification Committee of the International Headache Society. HIS The International Classification of Headache Disorders, 3rd ed. Cephalalgia. 2018; 38 (1): 1–211. DOI: 10.1177/0333102417738202
15. Rosenberg JH, Silberstein SD. The headache of SAH responds to sumatriptan. Headache. 2005; 45: 597. DOI: 10.1111/j.1526-4610.2005.05114.x
16. Leira EC, Cruz-Flores S, Leacock RO. Sumatriptan can alleviate headaches due to carotid artery dissection. Headache. 2001; 41: 590. DOI: 10.1046/j.1526-4610.2001.041006590.x
17. Prokhorov S, Khanna S, Alapati D. Subcutaneous sumatriptan relieved migraine-like headache in two adolescents with aseptic meningitis. Headache. 2008; 48: 1235. DOI: 10.1111/j.1526-4610.2008.01151.x
18. Lipton RB, Mazer C, Newman LC. Sumatriptan relieves migraine-like headaches associated with carbon monoxide exposure. Headache. 1997; 37: 392. DOI: 10.1046/j.1526-4610.1997.3706392.x
19. Luciani M, Negro A, Spunatrelli V, et al. Evaluating and managing severe headache in the emergency department. Expert Rev Neurother. 2021; 21 (3): 277–85. DOI: 10.1080/14737175.2021.1863148
20. Förderreuther S. Kopfschmerzen als Notfall sind leicht übersehen. Schmerz. 2020; 34: 517–24. DOI: 10.1007/s00482-020-00513-6
21. Vidale S. Headache in cervicocerebral artery dissection. Neurol Sci. 2020; 41: 395–9.
DOI: 10.1007/s10072-020-04651-8
22. Diamanti S, Longoni M, Agostoni EC. Leading symptoms in cerebrovascular diseases: what about headache? Neurol Sci. 2019; 40 (1): 147–52. DOI: 10.1007/s10072-019-03793-8
23. Tarulli A. Headache and Facial Pain. Neurology. 2020: 265–87. DOI: 10.1007/978-3-030-55598-6_19
24. Sekhon S, Sharma R, Cascella M. Thunderclap Headache. In: StatPearls. Treasure Island: StatPearls Publishing, 2020.
25. Miller TR, Shivashankar R, Mossa-Basha M, Gandhi D. Reversible Cerebral Vasoconstriction Syndrome, Part 1: Epidemiology, Pathogenesis, and Clinical Course. Am J Neuroradiol. 2015; 36 (8): 1392–9. DOI: 10.3174/ajnr.A4214
26. Ju YE, Schwedt TJ. Abrupt-onset severe headaches. Semin Neurol. 2010; 30 (2): 192–200.
DOI: 10.1055/s-0030-1249229
27. Devenney E, Neale H, Forbes RB. A systematic review of causes of sudden and severe headache (Thunderclap Headache): should lists be evidence based? J Headache Pain. 2014; 15 (1): 49. DOI: 10.1186/1129-2377-15-49
28. Joshi SG, Cho TA. Pathophysiological mechanisms of headache in patients with HIV. Headache. 2014; 54 (5): 946–50. DOI: 10.1111/head.12356
29. Brouwer MC, Coutinho JM, van de Beek D. Clinical characteristics and outcome of brain abscess: systematic review and meta-analysis. Neurology. 2014; 82 (9): 806–13. DOI: 10.1212/WNL.0000000000000172
30. Schankin CJ, Ferrari U, Reinisch VM. Characteristics of brain tumour-associated headache. Cephalalgia. 2007; 27 (8): 904–11. DOI: 10.1111/j.1468-2982.2007.01368.x
31. Palmieri A, Valentinis L, Zanchin G. Update on headache and brain tumors. Cephalalgia. 2020: 0333102420974351. DOI: 10.1177/0333102420974351
32. Chechet EA, Tabeeva GR. Tservikogennaia golovnaia bol'. Meditsinskii sovet. 2015; 4: 76–81. Available at: https://cyberleninka.ru/article/n/tservikogennaya-golovnaya-bol-2. Accessed: 07.04.2021 (in Russian).
33. Aliprandi A, Borelli P, Polonia V, Salmaggi A. Headache in cerebral venous thrombosis. Neurol Sci. 2020; 41 (2): 401–6. DOI: 10.1007/s10072-020-04784-w
34. Aladakatti R, Sannakki LB, Cai PY, Derequito R. Thunderclap headache: It is always sub-arachnoid hemorrhage. Is it? A case report and Review. Surg Neurol Int. 2014; 5: 22. DOI: 10.4103/2152-7806.127756
35. Negro A, Spuntarelli V, Sciattella P. Rapid referral for headache management from emergency department to headache centre: four years data. J Headache Pain. 2020; 21 (25): 1–11. DOI: 10.1186/s10194-020-01094-6
36. Valade D, Lucas C, Calvel L. Migraine diagnosis and management in general emergency departments in France. Cephalalgia. 2011; 31: 471–80. DOI: 10.1177/0333102410378178
37. Gupta MX, Silberstein SD, Young WB. Less is not more: Underutilization of headache medications in a university hospital emergency department. Headache. 2007; 47: 1125–33. DOI: 10.1111/j.1526-4610.2007.00846.x
38. Varrassi G, Pergolizzi JV, Dowling P, Paladini A. Ibuprofen safety at the golden anniversary: are all NSAIDs the same? A narrative review. Adv Ther. 2020; 37 (1): 61–82. DOI: 10.1007/s12325-019-01144-9
39. Moore RA, Derry S, Straube S, et al. Faster, higher, stronger? Evidence for formulation and efficacy for ibuprofen in acute pain. Pain. 2014; 155 (1): 14–21. DOI: 10.1016/j.pain.2013.08.013
40. Moore RA, Derry S, McQuay HJ, Wiffen PJ. Single dose oral analgesics for acute postoperative pain in adults. Cochrane Database Syst Rev. 2011: CD008659. DOI: 10.1002/14651858.CD008659.pub3
41. Van Den Brink MA, de Vries T, Danser AHJ. Headache medication and the COVID-19 pandemic.
J Headache Pain. 2020; 21 (1): 38. DOI: 10.1186/s10194-020-01106-5
42. Peck J, Urits I, Zeien J, et al. A Comprehensive Review of Over-the-counter Treatment for Chronic Migraine Headaches. Curr Pain Headache Rep. 2020; 24 (5): 19. DOI: 10.1007/s11916-020-00852-0
43. Rabbie R, Derry S, Moore RA, McQuay HJ. Ibuprofen with or without an antiemetic for acute migraine headaches in adults. Cochrane Database Syst Rev. 2010; 4. DOI: 10.1002/14651858.CD008039.pub2
2. Vos T, Flaxman AD, Naghavi M. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380 (9859): 2163–96. DOI: 10.1016/S0140-6736(12)61729-2
3. GBD 2015 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016; 388 (10053): 1603–58. DOI: 10.1016/S0140-6736(16)31460-X
4. Saylor D, Steiner TJ. The global burden of headache. Semin Neurol. 2018; 38 (2): 182–90. DOI: 10.1055/s-00000071
5. Ayzenberg I, Katsarava Z, Sborowski A. Headache-attributed burden and its impact on productivity and quality of life in Russia: structured healthcare for headache is urgently needed. Eur J Neurol. 2014; 21 (05): 758–65. DOI: 10.1111/ene.12380
6. Mukendi D, Lilo Kalo JR, Mpanya A. Clinical spectrum, etiology, and outcome of neurological disorders in the rural hospital of Mosango, the Democratic Republic of Congo. Am J Trop Med Hyg. 2017; 97 (05): 1454–60. DOI: 10.4269/ajtmh.17-0375
7. Gatti F, Manneschi L. Headache relevance in outpatient activity during Covid-19 pandemic. Neurol Sci. 2020; 41 (2): 481–2. DOI: 10.1007/s10072-020-04666-1
8. Ong JJY, Bharatendu C, Goh Y, et al. Headaches Associated with Personal Protective Equipment – a cross-sectional study amongst frontline healthcare workers during COVID-19 (HAPPE Study). Headache. 2020; 60: 864–77. DOI: 10.1111/head.13811
9. Caronna E, Ballvé A, Llauradó A, et al. Headache: A striking prodromal and persistent symptom, predictive of COVID-19 clinical evolution. Cephalalgia. 2020; 40 (13): 1410–21. DOI: 10.1177/0333102420965157
10. Pohl H, Do TP, García-Azorín D, et al. Green Flags and headache: A concept study using the Delphi method. Headache. 2021; 61 (2): 300–9. DOI: 10.1111/head.14054
11. Наприенко М.В., Филатова Е.Г., Смекалкина Л.В., Макаров С.А. Головная боль напряжения. Повторение пройденного. Consilium Medicum. 2019; 21 (2): 79–85 [Naprienko MV, Filatova EG, Smekalkina LV, Makarov SA. Tension headache. Let us get a second look. Consilium Medicum. 2019; 21 (2): 79–85 (in Russian)]. DOI: 10.26442/20751753.2019.2.190281
12. Осипова В.В., Филатова Е.Г., Артеменко А.Р., и др. Диагностика и лечение мигрени: рекомендации российских экспертов. Журнал неврологии и психиатрии им. С.С. Корсакова. 2017; 117 (1–2): 28–42 [Filatova EG, Osipova VV, Tabeeva GR, et al. Diagnosis and treatment of migraine: Recommendations of the Russian experts. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 2017; 117 (1–2): 28–42 (in Russian)]. DOI: 10.17116/jnevro20171171228-42
13. Longoni M, Agostoni EC. Headache in neurological emergency. Neurol Sci. 2020; 41 (2): 409–16. DOI: 10.1007/s10072-020-04761-3
14. Headache Classification Committee of the International Headache Society. HIS The International Classification of Headache Disorders, 3rd ed. Cephalalgia. 2018; 38 (1): 1–211. DOI: 10.1177/0333102417738202
15. Rosenberg JH, Silberstein SD. The headache of SAH responds to sumatriptan. Headache. 2005; 45: 597. DOI: 10.1111/j.1526-4610.2005.05114.x
16. Leira EC, Cruz-Flores S, Leacock RO. Sumatriptan can alleviate headaches due to carotid artery dissection. Headache. 2001; 41: 590. DOI: 10.1046/j.1526-4610.2001.041006590.x
17. Prokhorov S, Khanna S, Alapati D. Subcutaneous sumatriptan relieved migraine-like headache in two adolescents with aseptic meningitis. Headache. 2008; 48: 1235. DOI: 10.1111/j.1526-4610.2008.01151.x
18. Lipton RB, Mazer C, Newman LC. Sumatriptan relieves migraine-like headaches associated with carbon monoxide exposure. Headache. 1997; 37: 392. DOI: 10.1046/j.1526-4610.1997.3706392.x
19. Luciani M, Negro A, Spunatrelli V, et al. Evaluating and managing severe headache in the emergency department. Expert Rev Neurother. 2021; 21 (3): 277–85. DOI: 10.1080/14737175.2021.1863148
20. Förderreuther S. Kopfschmerzen als Notfall sind leicht übersehen. Schmerz. 2020; 34: 517–24. DOI: 10.1007/s00482-020-00513-6
21. Vidale S. Headache in cervicocerebral artery dissection. Neurol Sci. 2020; 41: 395–9.
DOI: 10.1007/s10072-020-04651-8
22. Diamanti S, Longoni M, Agostoni EC. Leading symptoms in cerebrovascular diseases: what about headache? Neurol Sci. 2019; 40 (1): 147–52. DOI: 10.1007/s10072-019-03793-8
23. Tarulli A. Headache and Facial Pain. Neurology. 2020: 265–87. DOI: 10.1007/978-3-030-55598-6_19
24. Sekhon S, Sharma R, Cascella M. Thunderclap Headache. In: StatPearls. Treasure Island: StatPearls Publishing, 2020.
25. Miller TR, Shivashankar R, Mossa-Basha M, Gandhi D. Reversible Cerebral Vasoconstriction Syndrome, Part 1: Epidemiology, Pathogenesis, and Clinical Course. Am J Neuroradiol. 2015; 36 (8): 1392–9. DOI: 10.3174/ajnr.A4214
26. Ju YE, Schwedt TJ. Abrupt-onset severe headaches. Semin Neurol. 2010; 30 (2): 192–200.
DOI: 10.1055/s-0030-1249229
27. Devenney E, Neale H, Forbes RB. A systematic review of causes of sudden and severe headache (Thunderclap Headache): should lists be evidence based? J Headache Pain. 2014; 15 (1): 49. DOI: 10.1186/1129-2377-15-49
28. Joshi SG, Cho TA. Pathophysiological mechanisms of headache in patients with HIV. Headache. 2014; 54 (5): 946–50. DOI: 10.1111/head.12356
29. Brouwer MC, Coutinho JM, van de Beek D. Clinical characteristics and outcome of brain abscess: systematic review and meta-analysis. Neurology. 2014; 82 (9): 806–13. DOI: 10.1212/WNL.0000000000000172
30. Schankin CJ, Ferrari U, Reinisch VM. Characteristics of brain tumour-associated headache. Cephalalgia. 2007; 27 (8): 904–11. DOI: 10.1111/j.1468-2982.2007.01368.x
31. Palmieri A, Valentinis L, Zanchin G. Update on headache and brain tumors. Cephalalgia. 2020: 0333102420974351. DOI: 10.1177/0333102420974351
32. Чечет Е.А., Табеева Г.Р. Цервикогенная головная боль. Медицинский совет. 2015; 4: 76–81. Режим доступа: https://cyberleninka.ru/article/n/tservikogennaya-golovnaya-bol-2. Ссылка активна на 07.04.2021 [Chechet EA, Tabeeva GR. Tservikogennaia golovnaia bol'. Meditsinskii sovet. 2015; 4: 76–81. Available at: https://cyberleninka.ru/article/n/tservikogennaya-golovnaya-bol-2. Accessed: 07.04.2021 (in Russian)].
33. Aliprandi A, Borelli P, Polonia V, Salmaggi A. Headache in cerebral venous thrombosis. Neurol Sci. 2020; 41 (2): 401–6. DOI: 10.1007/s10072-020-04784-w
34. Aladakatti R, Sannakki LB, Cai PY, Derequito R. Thunderclap headache: It is always sub-arachnoid hemorrhage. Is it? A case report and Review. Surg Neurol Int. 2014; 5: 22. DOI: 10.4103/2152-7806.127756
35. Negro A, Spuntarelli V, Sciattella P. Rapid referral for headache management from emergency department to headache centre: four years data. J Headache Pain. 2020; 21 (25): 1–11. DOI: 10.1186/s10194-020-01094-6
36. Valade D, Lucas C, Calvel L. Migraine diagnosis and management in general emergency departments in France. Cephalalgia. 2011; 31: 471–80. DOI: 10.1177/0333102410378178
37. Gupta MX, Silberstein SD, Young WB. Less is not more: Underutilization of headache medications in a university hospital emergency department. Headache. 2007; 47: 1125–33. DOI: 10.1111/j.1526-4610.2007.00846.x
38. Varrassi G, Pergolizzi JV, Dowling P, Paladini A. Ibuprofen safety at the golden anniversary: are all NSAIDs the same? A narrative review. Adv Ther. 2020; 37 (1): 61–82. DOI: 10.1007/s12325-019-01144-9
39. Moore RA, Derry S, Straube S, et al. Faster, higher, stronger? Evidence for formulation and efficacy for ibuprofen in acute pain. Pain. 2014; 155 (1): 14–21. DOI: 10.1016/j.pain.2013.08.013
40. Moore RA, Derry S, McQuay HJ, Wiffen PJ. Single dose oral analgesics for acute postoperative pain in adults. Cochrane Database Syst Rev. 2011: CD008659. DOI: 10.1002/14651858.CD008659.pub3
41. Van Den Brink MA, de Vries T, Danser AHJ. Headache medication and the COVID-19 pandemic.
J Headache Pain. 2020; 21 (1): 38. DOI: 10.1186/s10194-020-01106-5
42. Peck J, Urits I, Zeien J, et al. A Comprehensive Review of Over-the-counter Treatment for Chronic Migraine Headaches. Curr Pain Headache Rep. 2020; 24 (5): 19. DOI: 10.1007/s11916-020-00852-0
43. Rabbie R, Derry S, Moore RA, McQuay HJ. Ibuprofen with or without an antiemetic for acute migraine headaches in adults. Cochrane Database Syst Rev. 2010; 4. DOI: 10.1002/14651858.CD008039.pub2
________________________________________________
2. Vos T, Flaxman AD, Naghavi M. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380 (9859): 2163–96. DOI: 10.1016/S0140-6736(12)61729-2
3. GBD 2015 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016; 388 (10053): 1603–58. DOI: 10.1016/S0140-6736(16)31460-X
4. Saylor D, Steiner TJ. The global burden of headache. Semin Neurol. 2018; 38 (2): 182–90. DOI: 10.1055/s-00000071
5. Ayzenberg I, Katsarava Z, Sborowski A. Headache-attributed burden and its impact on productivity and quality of life in Russia: structured healthcare for headache is urgently needed. Eur J Neurol. 2014; 21 (05): 758–65. DOI: 10.1111/ene.12380
6. Mukendi D, Lilo Kalo JR, Mpanya A. Clinical spectrum, etiology, and outcome of neurological disorders in the rural hospital of Mosango, the Democratic Republic of Congo. Am J Trop Med Hyg. 2017; 97 (05): 1454–60. DOI: 10.4269/ajtmh.17-0375
7. Gatti F, Manneschi L. Headache relevance in outpatient activity during Covid-19 pandemic. Neurol Sci. 2020; 41 (2): 481–2. DOI: 10.1007/s10072-020-04666-1
8. Ong JJY, Bharatendu C, Goh Y, et al. Headaches Associated with Personal Protective Equipment – a cross-sectional study amongst frontline healthcare workers during COVID-19 (HAPPE Study). Headache. 2020; 60: 864–77. DOI: 10.1111/head.13811
9. Caronna E, Ballvé A, Llauradó A, et al. Headache: A striking prodromal and persistent symptom, predictive of COVID-19 clinical evolution. Cephalalgia. 2020; 40 (13): 1410–21. DOI: 10.1177/0333102420965157
10. Pohl H, Do TP, García-Azorín D, et al. Green Flags and headache: A concept study using the Delphi method. Headache. 2021; 61 (2): 300–9. DOI: 10.1111/head.14054
11. Naprienko MV, Filatova EG, Smekalkina LV, Makarov SA. Tension headache. Let us get a second look. Consilium Medicum. 2019; 21 (2): 79–85 (in Russian). DOI: 10.26442/20751753.2019.2.190281
12. Filatova EG, Osipova VV, Tabeeva GR, et al. Diagnosis and treatment of migraine: Recommendations of the Russian experts. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 2017; 117 (1–2): 28–42 (in Russian). DOI: 10.17116/jnevro20171171228-42
13. Longoni M, Agostoni EC. Headache in neurological emergency. Neurol Sci. 2020; 41 (2): 409–16. DOI: 10.1007/s10072-020-04761-3
14. Headache Classification Committee of the International Headache Society. HIS The International Classification of Headache Disorders, 3rd ed. Cephalalgia. 2018; 38 (1): 1–211. DOI: 10.1177/0333102417738202
15. Rosenberg JH, Silberstein SD. The headache of SAH responds to sumatriptan. Headache. 2005; 45: 597. DOI: 10.1111/j.1526-4610.2005.05114.x
16. Leira EC, Cruz-Flores S, Leacock RO. Sumatriptan can alleviate headaches due to carotid artery dissection. Headache. 2001; 41: 590. DOI: 10.1046/j.1526-4610.2001.041006590.x
17. Prokhorov S, Khanna S, Alapati D. Subcutaneous sumatriptan relieved migraine-like headache in two adolescents with aseptic meningitis. Headache. 2008; 48: 1235. DOI: 10.1111/j.1526-4610.2008.01151.x
18. Lipton RB, Mazer C, Newman LC. Sumatriptan relieves migraine-like headaches associated with carbon monoxide exposure. Headache. 1997; 37: 392. DOI: 10.1046/j.1526-4610.1997.3706392.x
19. Luciani M, Negro A, Spunatrelli V, et al. Evaluating and managing severe headache in the emergency department. Expert Rev Neurother. 2021; 21 (3): 277–85. DOI: 10.1080/14737175.2021.1863148
20. Förderreuther S. Kopfschmerzen als Notfall sind leicht übersehen. Schmerz. 2020; 34: 517–24. DOI: 10.1007/s00482-020-00513-6
21. Vidale S. Headache in cervicocerebral artery dissection. Neurol Sci. 2020; 41: 395–9.
DOI: 10.1007/s10072-020-04651-8
22. Diamanti S, Longoni M, Agostoni EC. Leading symptoms in cerebrovascular diseases: what about headache? Neurol Sci. 2019; 40 (1): 147–52. DOI: 10.1007/s10072-019-03793-8
23. Tarulli A. Headache and Facial Pain. Neurology. 2020: 265–87. DOI: 10.1007/978-3-030-55598-6_19
24. Sekhon S, Sharma R, Cascella M. Thunderclap Headache. In: StatPearls. Treasure Island: StatPearls Publishing, 2020.
25. Miller TR, Shivashankar R, Mossa-Basha M, Gandhi D. Reversible Cerebral Vasoconstriction Syndrome, Part 1: Epidemiology, Pathogenesis, and Clinical Course. Am J Neuroradiol. 2015; 36 (8): 1392–9. DOI: 10.3174/ajnr.A4214
26. Ju YE, Schwedt TJ. Abrupt-onset severe headaches. Semin Neurol. 2010; 30 (2): 192–200.
DOI: 10.1055/s-0030-1249229
27. Devenney E, Neale H, Forbes RB. A systematic review of causes of sudden and severe headache (Thunderclap Headache): should lists be evidence based? J Headache Pain. 2014; 15 (1): 49. DOI: 10.1186/1129-2377-15-49
28. Joshi SG, Cho TA. Pathophysiological mechanisms of headache in patients with HIV. Headache. 2014; 54 (5): 946–50. DOI: 10.1111/head.12356
29. Brouwer MC, Coutinho JM, van de Beek D. Clinical characteristics and outcome of brain abscess: systematic review and meta-analysis. Neurology. 2014; 82 (9): 806–13. DOI: 10.1212/WNL.0000000000000172
30. Schankin CJ, Ferrari U, Reinisch VM. Characteristics of brain tumour-associated headache. Cephalalgia. 2007; 27 (8): 904–11. DOI: 10.1111/j.1468-2982.2007.01368.x
31. Palmieri A, Valentinis L, Zanchin G. Update on headache and brain tumors. Cephalalgia. 2020: 0333102420974351. DOI: 10.1177/0333102420974351
32. Chechet EA, Tabeeva GR. Tservikogennaia golovnaia bol'. Meditsinskii sovet. 2015; 4: 76–81. Available at: https://cyberleninka.ru/article/n/tservikogennaya-golovnaya-bol-2. Accessed: 07.04.2021 (in Russian).
33. Aliprandi A, Borelli P, Polonia V, Salmaggi A. Headache in cerebral venous thrombosis. Neurol Sci. 2020; 41 (2): 401–6. DOI: 10.1007/s10072-020-04784-w
34. Aladakatti R, Sannakki LB, Cai PY, Derequito R. Thunderclap headache: It is always sub-arachnoid hemorrhage. Is it? A case report and Review. Surg Neurol Int. 2014; 5: 22. DOI: 10.4103/2152-7806.127756
35. Negro A, Spuntarelli V, Sciattella P. Rapid referral for headache management from emergency department to headache centre: four years data. J Headache Pain. 2020; 21 (25): 1–11. DOI: 10.1186/s10194-020-01094-6
36. Valade D, Lucas C, Calvel L. Migraine diagnosis and management in general emergency departments in France. Cephalalgia. 2011; 31: 471–80. DOI: 10.1177/0333102410378178
37. Gupta MX, Silberstein SD, Young WB. Less is not more: Underutilization of headache medications in a university hospital emergency department. Headache. 2007; 47: 1125–33. DOI: 10.1111/j.1526-4610.2007.00846.x
38. Varrassi G, Pergolizzi JV, Dowling P, Paladini A. Ibuprofen safety at the golden anniversary: are all NSAIDs the same? A narrative review. Adv Ther. 2020; 37 (1): 61–82. DOI: 10.1007/s12325-019-01144-9
39. Moore RA, Derry S, Straube S, et al. Faster, higher, stronger? Evidence for formulation and efficacy for ibuprofen in acute pain. Pain. 2014; 155 (1): 14–21. DOI: 10.1016/j.pain.2013.08.013
40. Moore RA, Derry S, McQuay HJ, Wiffen PJ. Single dose oral analgesics for acute postoperative pain in adults. Cochrane Database Syst Rev. 2011: CD008659. DOI: 10.1002/14651858.CD008659.pub3
41. Van Den Brink MA, de Vries T, Danser AHJ. Headache medication and the COVID-19 pandemic.
J Headache Pain. 2020; 21 (1): 38. DOI: 10.1186/s10194-020-01106-5
42. Peck J, Urits I, Zeien J, et al. A Comprehensive Review of Over-the-counter Treatment for Chronic Migraine Headaches. Curr Pain Headache Rep. 2020; 24 (5): 19. DOI: 10.1007/s11916-020-00852-0
43. Rabbie R, Derry S, Moore RA, McQuay HJ. Ibuprofen with or without an antiemetic for acute migraine headaches in adults. Cochrane Database Syst Rev. 2010; 4. DOI: 10.1002/14651858.CD008039.pub2
Авторы
Г.Р. Табеева*, Е.А. Кирьянова
ФГАОУ ВО «Первый Московский государственный медицинский университет им. И.М. Сеченова» Минздрава России (Сеченовский Университет), Москва, Россия
*grtabeeva@gmail.com
Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia
*grtabeeva@gmail.com
ФГАОУ ВО «Первый Московский государственный медицинский университет им. И.М. Сеченова» Минздрава России (Сеченовский Университет), Москва, Россия
*grtabeeva@gmail.com
________________________________________________
Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia
*grtabeeva@gmail.com
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.